Cargando…

PIV-21 Respiratory viral infections in adult patients with hematologic malignancies

Detalles Bibliográficos
Autores principales:	Bayram, A., Eksi, F., Okan, V., Balci, I., Yilmaz, M., Pehlivan, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2009
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128916/ http://dx.doi.org/10.1016/S1386-6532(09)70117-9

Ejemplares similares

PIV-27 Viral pathogens of respiratory tract infections in Ankara, Turkey
por: Altas, A.B., et al.
Publicado: (2009)

PIV-24 Multiple agents commonly involved in respiratory tract infections in children
por: Nordbø, S.A., et al.
Publicado: (2009)

PIV-23 Clinical usefulness of HMPV quantitative PCR in paediatric respiratory samples
por: Verroken, A., et al.
Publicado: (2009)

PIV-1 Respifinderplus for the diagnostics of respiratory infections with a focus on the 2009 A/H1N1 pandemic
por: Dumoulin, A., et al.
Publicado: (2009)

Respiratory Viral Infections in Children and Adolescents with Hematological Malignancies
por: Han, Seung Beom, et al.
Publicado: (2019)

2120. Respiratory Viral Infections in Patients with Hematologic Malignancies
por: Cardenas, Jorge Luis, et al.
Publicado: (2022)

Immunohistochemistry analysis of pulmonary infiltrates in necropsy samples of children with non-pandemic lethal respiratory infections (RSV; ADV; PIV1; PIV2; PIV3; FLU A; FLU B)
por: de Souza Costa, Victor Horácio, et al.
Publicado: (2014)

PIV-35 Evaluation of two newly developed QIAsymphony sp protocols for efficient isolation of influenza virus RNA from different respiratory samples
por: Hanselle, T., et al.
Publicado: (2009)

1119 Respiratory Viral Infections in a Cohort of Patients with Hematological Malignancies
por: Vilar-Compte, Diana, et al.
Publicado: (2014)

Viral infections in patients with hematological malignancies
por: Busca, A
Publicado: (2012)

Viral Respiratory Infections in Hematological Patients
por: Gabutti, Giovanni, et al.
Publicado: (2020)

COVID-19 Infection in Children with Down Syndrome and Hematologic Malignancies
por: Foxworthy, Blake, et al.
Publicado: (2022)

1104. Characteristics and Seasonality of Children Hospitalized with Parainfluenza Virus Infections (PIV), including PIV-4, New Vaccine Surveillance Network, 2016–2020
por: de St. Maurice, Annabelle M, et al.
Publicado: (2023)

PIV-37 Do viral respiratory co-pathogens contribute to morbidity & mortality in an outbreak of parainfluenza type 3 in haematology-oncology patients?
por: Sehmi, J.K., et al.
Publicado: (2009)

355. Invasive Pulmonary Aspergillosis (IPA) Complicating Respiratory Viral Infections in Patients With Hematological Malignancies
por: Magira, Eleni, et al.
Publicado: (2018)

Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas
por: Topkan, Erkan, et al.
Publicado: (2022)

Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies
por: Chien, Kelly S., et al.
Publicado: (2022)

Sepsis and neutropenia in hematological malignancies
por: Labiad, Y, et al.
Publicado: (2014)

P1700: EARLY APPEARANCE OF CARDIOTOXICITY, IN CHILDREN WITH HEMATOLOGICAL MALIGNANCIES (HM)
por: Antoniadi, K., et al.
Publicado: (2022)

Pressure from 2D snapshot PIV
por: Van der Kindere, J. W., et al.
Publicado: (2019)

Progress towards a Miniaturised PIV System
por: Özer, Özgün, et al.
Publicado: (2022)

Is admission of hematologic malignancies in the ICU justified?
por: Gasparovic, VG, et al.
Publicado: (2015)

P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19
por: Chudnova, T., et al.
Publicado: (2022)

PIV-28 Detection of respiratory viruses by molecular methods – a way of improving conventional diagnosis
por: Arroyo, L. García, et al.
Publicado: (2009)

Algorithm for empirical glycopeptide treatment in patients with hematologic malignancies and enterococcus faecium blood stream infection
por: Zhou, X, et al.
Publicado: (2011)

Outcomes of patients with hematologic malignancies admitted to the ICU
por: Duayer, I, et al.
Publicado: (2015)

P1745: ADHERENCE TO TREATMENT OF HEMATOLOGICAL MALIGNANCIES PATIENTS WITH ANXIETY AND DEPRESSION
por: Vybornykh, D. E., et al.
Publicado: (2022)

PIV-26 Human bocavirus-monoinfection and viremia are associated with airway infection in children
por: Christensen, A., et al.
Publicado: (2009)

Predictors of poor outcomes in critically ill patients with hematologic malignancy
por: Cornish, M, et al.
Publicado: (2015)

Memorandum: request to reinstall PS185 in PIV/85
por: Kilian, K
Publicado: (1985)

Experimental research on intraocular aqueous flow by PIV method
por: Yang, Hongyu, et al.
Publicado: (2013)

PIV-20 Detection of WU/KI polyomaviruses in respiratory samples from Leeds Teaching Hospitals NHS Trust
por: Saundh, B., et al.
Publicado: (2009)

Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies
por: Vakil, Erik, et al.
Publicado: (2018)

Hemodynamic Study of a Patient-Specific Intracranial Aneurysm: Comparative Assessment of Tomographic PIV, Stereoscopic PIV, In Vivo MRI and Computational Fluid Dynamics
por: Wu, Xiaolin, et al.
Publicado: (2021)

Prediction of Mortality Following Cytokine Storm in Patients with Hematological Malignancies and COVID-19 Infections
por: Prakash, Rishab, et al.
Publicado: (2022)

Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study
por: Magira, Eleni E, et al.
Publicado: (2019)

P1574: EFFICACY AND SAFETY OF TIXAGEVIMAB AND CILGAVIMAB (EVUSHELD) IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
por: Aleshina (Gavrilina), Olga, et al.
Publicado: (2023)

Targeting hematologic malignancies with oncolytic vaccinia virus constructs
por: Chen, Nanhai, et al.
Publicado: (2013)

Are Community Acquired Respiratory Viral Infections an Underestimated Burden in Hematology Patients?
por: Popescu, Cristian-Marian, et al.
Publicado: (2019)

1095. Investigation of Risk Factors Associated with Serious Bacterial, Viral and Invasive Fungal Infections in Hematologic Patients on Ibrutinib
por: Holowka, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h8bmve8fkgchng85gid503b4m4